日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection

长效注射贝达喹啉制剂在潜伏性结核感染少菌小鼠模型中的活性

Amit Kaushik #, Nicole C Ammerman #, Sandeep Tyagi, Vikram Saini, Iwan Vervoort, Sophie Lachau-Durand, Eric Nuermberger, Koen Andries

Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis

pepQ 突变导致结核分枝杆菌对贝达喹啉和氯法齐明产生低水平耐药性

Deepak Almeida, Thomas Ioerger, Sandeep Tyagi, Si-Yang Li, Khisimuzi Mdluli, Koen Andries, Jacques Grosset, Jim Sacchettini, Eric Nuermberger

Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism

结核分枝杆菌对贝达喹啉的延迟杀菌反应涉及细菌代谢的重塑

Anil Koul, Luc Vranckx, Neeraj Dhar, Hinrich W H Göhlmann, Emre Özdemir, Jean-Marc Neefs, Melanie Schulz, Ping Lu, Ejvind Mørtz, John D McKinney, Koen Andries, Dirk Bald

Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria

针对革兰氏阳性致病菌呼吸道 ATP 合成的新型抗生素

Wendy Balemans, Luc Vranckx, Nacer Lounis, Ovidiu Pop, Jérôme Guillemont, Karen Vergauwen, Selena Mol, Ron Gilissen, Magali Motte, David Lançois, Miguel De Bolle, Kristien Bonroy, Holger Lill, Koen Andries, Dirk Bald, Anil Koul

Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase

探究二芳基喹啉 TMC207 与其靶分枝杆菌 ATP 合酶的相互作用

Anna C Haagsma, Ioana Podasca, Anil Koul, Koen Andries, Jerome Guillemont, Holger Lill, Dirk Bald

A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides

一系列二芳基三嗪和二芳基嘧啶是高效的非核苷逆转录酶抑制剂,可用作杀微生物剂

Yven Van Herrewege, Guido Vanham, Jo Michiels, Katrien Fransen, Luc Kestens, Koen Andries, Paul Janssen, Paul Lewi